Banco Santander S.A. (ADR) (NYSE:SAN) trades flat

Posted by Lynn Eisler July 9, 2013 0 Comment 1599 views


Shares of Banco Santander S.A. (ADR) (NYSE:SAN) closed lower at $6.67 per share on Tuesday, recording a decline of 0.45 percent over the previous closing price. The shares of the company are presently fluctuating with intraday movements in the range of $6.59 to $6.73 per share, after opening at $6.72 per share. The shares of Banco Santander S.A. (ADR) (NYSE:SAN) recorded a 52-week low price of $4.88 per share and a 52 week-high price of $8.86 per share.

Banco Santander S.A. (ADR) (NYSE:SAN) had a trading volume of 5.46 million shares on Tuesday, with an average trading volume of 8.19 million shares per day. The company currently has 10.32 billion shares outstanding in the market which accounts for market capitalization of $68.79 billion. Institutional ownership in Banco Santander S.A. (ADR) (NYSE:SAN) is 1 percent of its total equity capital.

Banco Santander S.A. (ADR) (NYSE:SAN) closed a deal to sell 50 percent of the stake in its asset management wing with Warburg Pincus and General Atlantic LLC. Banco Santander S.A. (ADR) (NYSE:SAN) will obtain a net profit of $914 million from the deal. Santander Asset Management will be valued at $2.68 billion. The price to earnings ratio (P/E) of Banco Santander S.A. (ADR) (NYSE:SAN) for the current year is 23.00 as compared to the ten year average of the price to earnings ratio of 5.8. Banco Santander S.A. (ADR) (NYSE:SAN) maintained a value of €0.60 per share for the past five years, along with a 11.90 percent dividend yield, making the company one of the most attractive banks for the UK investors, as the largest bank of Spain. Banco Santander S.A. (ADR) (NYSE:SAN) made a provision of 18.80 billion Euros of expected bad debts, albeit the bank made a profit of 2.2 billion Euros.


About Lynn Eisler

Lynn Eisler is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments. Lynn has been honored with the H.L. Mencken Award for Investigative Reporting, the Champion of Justice Award for reporting on the drug war, and the John Hancock Award for business reporting. Lynn was also a Knight Medical School Fellow at the University of Michigan.

View all post by Lynn Eisler Visit author's website

Write Your Comment